{"id":"https://openalex.org/W3118272952","doi":"https://doi.org/10.1111/dom.14313","title":"Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR\u2010TIMI 53 cardiovascular outcomes trials","display_name":"Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR\u2010TIMI 53 cardiovascular outcomes trials","publication_year":2021,"publication_date":"2021-01-04","ids":{"openalex":"https://openalex.org/W3118272952","doi":"https://doi.org/10.1111/dom.14313","mag":"3118272952","pmid":"https://pubmed.ncbi.nlm.nih.gov/33394543"},"language":"en","primary_location":{"id":"doi:10.1111/dom.14313","doi":"https://doi.org/10.1111/dom.14313","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.14313","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012363916","display_name":"Lindsay E. Clegg","orcid":"https://orcid.org/0000-0001-8558-9341","observed_orcids":["https://orcid.org/0000-0001-8558-9341"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lindsay E. Clegg","raw_affiliation_strings":["Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca  Gaithersburg Maryland","Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Gaithersburg Maryland"],"raw_orcid":"https://orcid.org/0000-0001-8558-9341","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca  Gaithersburg Maryland","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Gaithersburg Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039020710","display_name":"Yankang Jing","orcid":"https://orcid.org/0009-0007-1979-5893","observed_orcids":["https://orcid.org/0009-0007-1979-5893"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yankang Jing","raw_affiliation_strings":["Department of Pharmaceutical Sciences, School of Pharmacy University of Pittsburgh  Pittsburgh Pennsylvania","Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, School of Pharmacy University of Pittsburgh  Pittsburgh Pennsylvania","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076548018","display_name":"Robert C. Penland","orcid":"https://orcid.org/0000-0003-2706-8913","observed_orcids":["https://orcid.org/0000-0003-2706-8913"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert C. Penland","raw_affiliation_strings":["Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca  Boston Massachusetts","Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Boston Massachusetts"],"raw_orcid":"https://orcid.org/0000-0003-2706-8913","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca  Boston Massachusetts","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Boston Massachusetts","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060128890","display_name":"David W. Boulton","orcid":"https://orcid.org/0000-0002-0668-7304","observed_orcids":["https://orcid.org/0000-0002-0668-7304"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David W. Boulton","raw_affiliation_strings":["Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca  Gaithersburg Maryland","Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Gaithersburg Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca  Gaithersburg Maryland","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Gaithersburg Maryland","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012849300","display_name":"Adrian F. Hernandez","orcid":"https://orcid.org/0000-0003-3387-9616","observed_orcids":["https://orcid.org/0000-0003-3387-9616"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrian F. Hernandez","raw_affiliation_strings":["Duke University and Duke Clinical Research Institute, Duke University School of Medicine  Durham North Carolina","Duke University and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University and Duke Clinical Research Institute, Duke University School of Medicine  Durham North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke University and Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049740900","display_name":"Rury R. Holman","orcid":"https://orcid.org/0000-0002-1256-874X","observed_orcids":["https://orcid.org/0000-0002-1256-874X"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rury R. Holman","raw_affiliation_strings":["Diabetes Trials Unit, Radcliffe Department of Medicine University of Oxford  Oxford UK","Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0002-1256-874X","affiliations":[{"raw_affiliation_string":"Diabetes Trials Unit, Radcliffe Department of Medicine University of Oxford  Oxford UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Diabetes Trials Unit, Radcliffe Department of Medicine, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090192766","display_name":"Jiten P Vora","orcid":"https://orcid.org/0000-0002-3488-5287","observed_orcids":["https://orcid.org/0000-0002-3488-5287"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jiten Vora","raw_affiliation_strings":["University of Liverpool  Liverpool UK","University of Liverpool, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Liverpool  Liverpool UK","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5012363916"],"corresponding_institution_ids":["https://openalex.org/I4210150756"],"apc_list":{"value":4700,"currency":"USD","value_usd":4700},"apc_paid":null,"fwci":0.9408,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.73723751,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"23","issue":"5","first_page":"1101","last_page":"1110"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8779000043869019,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8779000043869019,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.10849999636411667,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9300000071525574},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9160000085830688},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.9850000143051147},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9959999918937683},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.878000020980835},{"id":"https://openalex.org/keywords/lactic-acidosis","display_name":"lactic acidosis","score":0.9129999876022339},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.921999990940094},{"id":"https://openalex.org/keywords/saxagliptin","display_name":"saxagliptin","score":0.996999979019165},{"id":"https://openalex.org/keywords/exscel-trial","display_name":"EXSCEL trial","score":0.9259999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9275496006011963},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8826438188552856},{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.819445013999939},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6446455121040344},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.619817852973938},{"id":"https://openalex.org/C2777995511","wikidata":"https://www.wikidata.org/wiki/Q2897649","display_name":"TIMI","level":4,"score":0.5692489743232727},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5592841506004333},{"id":"https://openalex.org/C2780739214","wikidata":"https://www.wikidata.org/wiki/Q6723023","display_name":"Mace","level":4,"score":0.553429126739502},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4753192067146301},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.45886725187301636},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4316408038139343},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.26820293068885803},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2588039040565491},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.2461153268814087},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.24101263284683228},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.10799714922904968}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.14313","doi":"https://doi.org/10.1111/dom.14313","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.14313","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:33394543","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33394543","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5733052680","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0515-10096","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1494561942","https://openalex.org/W1521352086","https://openalex.org/W1968446955","https://openalex.org/W1986628483","https://openalex.org/W2064130493","https://openalex.org/W2112662675","https://openalex.org/W2144387798","https://openalex.org/W2146264128","https://openalex.org/W2152849583","https://openalex.org/W2167639134","https://openalex.org/W2188846692","https://openalex.org/W2200208573","https://openalex.org/W2425644022","https://openalex.org/W2469145885","https://openalex.org/W2519510391","https://openalex.org/W2570191103","https://openalex.org/W2582743722","https://openalex.org/W2588615098","https://openalex.org/W2626446274","https://openalex.org/W2743010525","https://openalex.org/W2754041380","https://openalex.org/W2781265137","https://openalex.org/W2782341309","https://openalex.org/W2900413769","https://openalex.org/W2902206260","https://openalex.org/W2914902752","https://openalex.org/W2948612418","https://openalex.org/W2966851967","https://openalex.org/W2974058425","https://openalex.org/W2981486868","https://openalex.org/W3009389584","https://openalex.org/W3019600263","https://openalex.org/W4246340431","https://openalex.org/W6741998469","https://openalex.org/W7074165410"],"related_works":["https://openalex.org/W2094058771","https://openalex.org/W2150483909","https://openalex.org/W3091494213","https://openalex.org/W2094649585","https://openalex.org/W2088180663","https://openalex.org/W2033331104","https://openalex.org/W2949067235","https://openalex.org/W2103058881","https://openalex.org/W2073314743","https://openalex.org/W2189353858"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"provide":[2],"evidence":[3],"on":[4,86,141,230],"the":[5,25,34,98,122,129,188,218],"cardiovascular":[6,77,214],"and":[7,33,36,80,97,155],"renal":[8],"safety":[9,220],"of":[10,28,74,100,174,204,221],"metformin":[11,56,112,137,186],"in":[12,24,39,120,180,187,193,198],"chronic":[13],"kidney":[14],"disease":[15],"(CKD)":[16],"stages":[17,208],"3":[18,209],"to":[19,55,71,134,210],"4.":[20],"MATERIALS":[21],"AND":[22],"METHODS:":[23],"Exenatide":[26],"Study":[27],"Cardiovascular":[29,37],"Event":[30],"Lowering":[31],"(EXSCEL)":[32],"Saxagliptin":[35],"Outcomes":[38],"Patients":[40],"With":[41],"Type":[42],"2":[43],"Diabetes":[44],"Mellitus":[45],"(SAVOR-TIMI":[46],"53)":[47],"trials":[48,216],"taking":[49],"metformin,":[50,222],"with":[51,114,165,172,185,206],"those":[52],"not":[53,197,225],"exposed":[54],"during":[57],"these":[58],"trials,":[59],"using":[60,91],"a":[61,92,227],"propensity-matching":[62],"approach.":[63],"Adjusted":[64],"Cox":[65],"proportional":[66],"hazards":[67],"models":[68],"were":[69],"used":[70],"assess":[72],"risk":[73],"major":[75],"adverse":[76],"events":[78,103],"(MACE)":[79],"all-cause":[81],"mortality":[82],"(ACM).":[83],"Metformin":[84],"effect":[85],"eGFR":[87,116,181,234],"slope":[88,182,235],"was":[89,104,118,183],"calculated":[90],"mixed-model":[93],"repeated":[94],"measures":[95],"analysis,":[96],"number":[99],"lactic":[101],"acidosis":[102],"tabulated.":[105],"RESULTS:":[106],"No":[107],"strong":[108],"trend":[109],"for":[110],"lower":[111,115],"doses":[113],"values":[117],"observed":[119,184],"either":[121],"EXSCEL":[123],"or":[124,171,176,233],"SAVOR-TIMI":[125,194],"53":[126],"trials.":[127],"In":[128],"1745":[130],"metformin-using":[131],"participants":[132,205],"matched":[133],"non-metformin":[135],"users,":[136],"had":[138],"neutral":[139],"effects":[140],"MACE":[142],"(hazard":[143],"ratio":[144],"[HR]":[145],"0.91,":[146],"95%":[147,159],"confidence":[148],"interval":[149],"[CI]":[150],"0.76-1.08;":[151],"P":[152,162],"=":[153,163],"0.28)":[154],"ACM":[156],"(HR":[157],"0.86,":[158],"CI":[160],"0.70-1.07;":[161],"0.18),":[164],"no":[166],"interaction":[167],"by":[168],"CKD":[169,189,207],"stage,":[170],"use":[173],"exenatide":[175],"saxagliptin.":[177],"An":[178],"improvement":[179],"stage":[190],"3B":[191],"cohort":[192],"53,":[195],"but":[196,223],"other":[199],"groups.":[200],"CONCLUSIONS:":[201],"This":[202],"analysis":[203],"4":[211],"from":[212],"two":[213],"outcomes":[215],"supports":[217],"cardiorenal":[219],"does":[224],"suggest":[226],"consistent":[228],"benefit":[229],"MACE,":[231],"ACM,":[232],"across":[236],"this":[237],"population.":[238]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-01-18T00:00:00"}